(Q33590797)

28 July 2017

title

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect (English)

1 reference

magnetic resonance imaging

28 July 2017

0 references

0 references

author name string

Miller DH

1

1 reference

28 July 2017

Thompson AJ

2

1 reference

28 July 2017

Morrissey SP

3

1 reference

28 July 2017

MacManus DG

4

1 reference

28 July 2017

Moore SG

5

1 reference

28 July 2017

Kendall BE

6

1 reference

28 July 2017

Moseley IF

7

1 reference

28 July 2017

McDonald WI

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1992

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

28 July 2017

published in

1 reference

28 July 2017

volume

55

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

450-453

1 reference

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Intravenous methylprednisolone for multiple sclerosis in relapse

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014899

Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.)

31 October 2018

1 reference

12 December 2020

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

1 reference

12 December 2020

Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations

1 reference

12 December 2020

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS

1 reference

12 December 2020

High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations

1 reference

12 December 2020

In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis

1 reference

12 December 2020

The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord

1 reference

12 December 2020

Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.55.6.450

1 reference

28 July 2017

1 reference

28 July 2017

1 reference